Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2000
07/06/2000CA2355096A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists
07/06/2000CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof
07/06/2000CA2354053A1 A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
07/06/2000CA2354052A1 Methods for treating certain diseases using naaladase inhibitors
07/06/2000CA2353961A1 Heteroaromatic derivatives having an inhibitory activity against hiv integrase
07/06/2000CA2352896A1 Pyrimidine compounds
07/06/2000CA2352423A1 Treatment of retroviral infections with oxyphenbutazone
07/06/2000CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates
07/06/2000CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
07/06/2000CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
07/06/2000CA2349557A1 Thrombin or factor xa inhibitors
07/06/2000CA2348740A1 Thrombin or factor xa inhibitors
07/06/2000CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production
07/06/2000CA2321864A1 Interleukin-6 production inhibitor
07/06/2000CA2321672A1 Caspase-8 interacting proteins
07/06/2000CA2320730A1 Thrombin or factor xa inhibitors
07/05/2000EP1016715A1 Oligonucleotides having a conserved G4 core sequence
07/05/2000EP1016669A1 New derivatives of erythromycin, process for making them as well as their use as medicaments
07/05/2000EP1016665A1 Process for the selective preparation of z-isomers of 3-(2-substituted vinyl)cephalosporins
07/05/2000EP1016664A1 Fused thiophene compounds and medicinal use thereof
07/05/2000EP1016646A1 Intermediates for the preparation of cephalosporines containing on the 7-position a substituted benzyloximino radical
07/05/2000EP1016411A1 Sulodexide for restenosis therapy
07/05/2000EP1016410A1 Glycosaminoglycans for the treatment for pre-eclampsia and related diseases
07/05/2000EP1016408A1 C-c chemokine production inhibitor
07/05/2000EP1016407A1 Remedial agent for neural degeneration
07/05/2000EP1016406A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
07/05/2000EP1016405A2 Arylating medicaments
07/05/2000EP1016404A1 Aqueous preparation of beta-carotene
07/05/2000EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
07/05/2000EP1015630A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
07/05/2000EP1015627A1 Method for detecting a target compound using a nucleic acid ligand
07/05/2000EP1015600A1 Statin production by fermentation
07/05/2000EP1015566A1 Human ste20-like stress activated serine/threonine kinase
07/05/2000EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
07/05/2000EP1015474A1 Don-1 gene and polypeptides and uses therefor
07/05/2000EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R)
07/05/2000EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
07/05/2000EP1015471A1 Hypoxia-regulated genes
07/05/2000EP1015470A1 Composition and method for delivery of nucleic acids
07/05/2000EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
07/05/2000EP1015467A1 6,9-bridged erythromycin derivatives
07/05/2000EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
07/05/2000EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives
07/05/2000EP1015458A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
07/05/2000EP1015457A1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors
07/05/2000EP1015456A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
07/05/2000EP1015455A1 Pyrrolopyrrolone derivatives
07/05/2000EP1015454A1 Method of inhibiting serine protease enzymes
07/05/2000EP1015453A1 3-(iodophenoxymethyl) carbapenem antibacterials
07/05/2000EP1015452A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
07/05/2000EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000EP1015450A1 Novel pyridazine compounds
07/05/2000EP1015449A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors
07/05/2000EP1015448A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
07/05/2000EP1015447A1 Piperidinylmethyloxazolidinone derivative
07/05/2000EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
07/05/2000EP1015445A1 Antimicrobial quinolones, their compositions and uses
07/05/2000EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof
07/05/2000EP1015443A1 Thromboxane ligands
07/05/2000EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors
07/05/2000EP1015439A1 Prenyl transferase inhibitors
07/05/2000EP1015438A1 Protease inhibitors
07/05/2000EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
07/05/2000EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
07/05/2000EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2
07/05/2000EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
07/05/2000EP1015427A1 Substituted 2-pyrrolidinone activators of pkc
07/05/2000EP1015423A1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs
07/05/2000EP1015422A1 Hiv matrix protein tyrosine position 29 pocket binders
07/05/2000EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments
07/05/2000EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
07/05/2000EP1015416A2 Method for the preparation of citalopram
07/05/2000EP1015413A1 Anti-cancer compounds
07/05/2000EP1015106A1 Betaine product, method for its manufacture, and its use
07/05/2000EP1015033A2 Substituted perylenequinones for use in photodynamic therapy
07/05/2000EP1015030A2 Photochemotherapeutic compositions
07/05/2000EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
07/05/2000EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines
07/05/2000EP1015022A1 New improved formulation for treatment of thromboembolism
07/05/2000EP1015019A1 Compositions and methods of therapy for igf-i-responsive conditions
07/05/2000EP1015011A1 Peptide nucleic acids having antibacterial activity
07/05/2000EP1015008A1 Compounds and compositions for delivering active agents
07/05/2000EP1015006A2 Cocoa extract compounds and methods for making and using the same
07/05/2000EP1015000A1 Antiviral polymers comprising acid functional and hydrophobic groups
07/05/2000EP1014999A1 Cationic polymers as toxin-binding agents
07/05/2000EP1014998A1 Polymeric compositions
07/05/2000EP1014997A1 Substance and method for reduction of lipids and cholesterol
07/05/2000EP1014996A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
07/05/2000EP1014995A1 Compositions and methods for preventing restenosis following revascularization procedures
07/05/2000EP1014994A1 Phosphono-carboxylate compounds for treating amyloidosis
07/05/2000EP1014993A1 New use for budesonide and formoterol
07/05/2000EP1014992A1 Use of delta 5-androstenes in the treatment of hiv wasting syndrome
07/05/2000EP1014991A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
07/05/2000EP1014990A1 Method of treating a tumor
07/05/2000EP1014989A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation
07/05/2000EP1014988A2 Treatment of hepatic cirrhosis
07/05/2000EP1014987A1 Oral compositions of levosimendan
07/05/2000EP1014986A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST
07/05/2000EP1014985A1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT 1B ANTAGONIST OR PARTIAL AGONIST
07/05/2000EP1014984A1 Inhibitors of prenyl-protein transferase